Illumina is trading 4.65% up at $292.46 as investors position ahead of its third-quarter results, due after market close on October 29.
- Analysts expect about $1.15 billion in revenue and $1.36 earnings per share.
- The biotech sector is up 2.18%, while major market indexes are mixed.
- One report described trading volume as light versus average earlier in the session.